KRYS•benzinga•
Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $218
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 20, 2025 by benzinga